Association between COVID-19 severity and relatively high serum adiponectin levels at the time of admission

At the beginning of 2020, coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) led to epidemics worldwide. Obesity and visceral fat accumulation have been reported to be independent risk factors for severe COVID-19. Several reports have focused o...

Full description

Saved in:
Bibliographic Details
Main Authors: Ryohei Mineo, Shiro Fukuda, Shigehito Suzuki, Yoshito Ito, Sachiko Tamba, Takuya Sugiyama, Yuya Fujishima, Hitoshi Nishizawa, Iichiro Shimomura, Koji Yamamoto, Yuji Matsuzawa
Format: Article
Language:English
Published: The Japan Endocrine Society 2024-07-01
Series:Endocrine Journal
Subjects:
Online Access:https://www.jstage.jst.go.jp/article/endocrj/71/7/71_EJ24-0072/_html/-char/en
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832591892726939648
author Ryohei Mineo
Shiro Fukuda
Shigehito Suzuki
Yoshito Ito
Sachiko Tamba
Takuya Sugiyama
Yuya Fujishima
Hitoshi Nishizawa
Iichiro Shimomura
Koji Yamamoto
Yuji Matsuzawa
author_facet Ryohei Mineo
Shiro Fukuda
Shigehito Suzuki
Yoshito Ito
Sachiko Tamba
Takuya Sugiyama
Yuya Fujishima
Hitoshi Nishizawa
Iichiro Shimomura
Koji Yamamoto
Yuji Matsuzawa
author_sort Ryohei Mineo
collection DOAJ
description At the beginning of 2020, coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) led to epidemics worldwide. Obesity and visceral fat accumulation have been reported to be independent risk factors for severe COVID-19. Several reports have focused on the levels of adipocytokines/adipokines, including adiponectin (APN), which is exclusively secreted from adipocytes, although the importance of these factors in acute disease conditions remains unclear. Therefore, we investigated the relationship between serum adiponectin levels and COVID-19 severity. Patients with COVID-19 who were admitted to Sumitomo Hospital (Osaka, Japan) from May through October 2021 were included. A total of 107 patients were enrolled in this study. We obtained the anthropometric and clinical laboratory data of the patients at the time of admission and examined the associations between various parameters and COVID-19 severity. The mean period from onset to admission was 6.5 ± 2.8 days. We divided the patients into “non-severe” (mild, moderate-I and moderate-II) (n = 80) and “severe” (n = 27) groups. The “severe” patients were significantly older than “non-severe” patients. Additionally, no significant differences were observed in BMI, sex, or the period from onset to admission. The serum adiponectin levels of “severe” patients at the time of admission were significantly greater than those of “non-severe” patients even after adjusting for age, sex, and BMI. These results suggest that the serum APN levels at the time of admission can predict COVID-19 severity. However, further investigations on the changes in APN levels in acute diseases are needed.
format Article
id doaj-art-19dcc408f73c4238b091b180ca2abbaa
institution Kabale University
issn 1348-4540
language English
publishDate 2024-07-01
publisher The Japan Endocrine Society
record_format Article
series Endocrine Journal
spelling doaj-art-19dcc408f73c4238b091b180ca2abbaa2025-01-22T05:12:18ZengThe Japan Endocrine SocietyEndocrine Journal1348-45402024-07-0171770571110.1507/endocrj.EJ24-0072endocrjAssociation between COVID-19 severity and relatively high serum adiponectin levels at the time of admissionRyohei Mineo0Shiro Fukuda1Shigehito Suzuki2Yoshito Ito3Sachiko Tamba4Takuya Sugiyama5Yuya Fujishima6Hitoshi Nishizawa7Iichiro Shimomura8Koji Yamamoto9Yuji Matsuzawa10Department of Endocrinology and Metabolism, Sumitomo Hospital, Osaka 530-0005, JapanDepartment of Metabolic Medicine, Graduate School of Medicine, Osaka University, Osaka 565-0871, JapanDepartment of Endocrinology and Metabolism, Sumitomo Hospital, Osaka 530-0005, JapanDepartment of Endocrinology and Metabolism, Sumitomo Hospital, Osaka 530-0005, JapanDepartment of Endocrinology and Metabolism, Sumitomo Hospital, Osaka 530-0005, JapanDepartment of Endocrinology and Metabolism, Sumitomo Hospital, Osaka 530-0005, JapanDepartment of Metabolic Medicine, Graduate School of Medicine, Osaka University, Osaka 565-0871, JapanDepartment of Metabolism and Atherosclerosis, Graduate School of Medicine, Osaka University, Osaka 565-0871, JapanDepartment of Metabolic Medicine, Graduate School of Medicine, Osaka University, Osaka 565-0871, JapanDepartment of Endocrinology and Metabolism, Sumitomo Hospital, Osaka 530-0005, JapanDepartment of Endocrinology and Metabolism, Sumitomo Hospital, Osaka 530-0005, JapanAt the beginning of 2020, coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) led to epidemics worldwide. Obesity and visceral fat accumulation have been reported to be independent risk factors for severe COVID-19. Several reports have focused on the levels of adipocytokines/adipokines, including adiponectin (APN), which is exclusively secreted from adipocytes, although the importance of these factors in acute disease conditions remains unclear. Therefore, we investigated the relationship between serum adiponectin levels and COVID-19 severity. Patients with COVID-19 who were admitted to Sumitomo Hospital (Osaka, Japan) from May through October 2021 were included. A total of 107 patients were enrolled in this study. We obtained the anthropometric and clinical laboratory data of the patients at the time of admission and examined the associations between various parameters and COVID-19 severity. The mean period from onset to admission was 6.5 ± 2.8 days. We divided the patients into “non-severe” (mild, moderate-I and moderate-II) (n = 80) and “severe” (n = 27) groups. The “severe” patients were significantly older than “non-severe” patients. Additionally, no significant differences were observed in BMI, sex, or the period from onset to admission. The serum adiponectin levels of “severe” patients at the time of admission were significantly greater than those of “non-severe” patients even after adjusting for age, sex, and BMI. These results suggest that the serum APN levels at the time of admission can predict COVID-19 severity. However, further investigations on the changes in APN levels in acute diseases are needed.https://www.jstage.jst.go.jp/article/endocrj/71/7/71_EJ24-0072/_html/-char/enadiponectincovid-19sars-cov-2severityacute phase of disease
spellingShingle Ryohei Mineo
Shiro Fukuda
Shigehito Suzuki
Yoshito Ito
Sachiko Tamba
Takuya Sugiyama
Yuya Fujishima
Hitoshi Nishizawa
Iichiro Shimomura
Koji Yamamoto
Yuji Matsuzawa
Association between COVID-19 severity and relatively high serum adiponectin levels at the time of admission
Endocrine Journal
adiponectin
covid-19
sars-cov-2
severity
acute phase of disease
title Association between COVID-19 severity and relatively high serum adiponectin levels at the time of admission
title_full Association between COVID-19 severity and relatively high serum adiponectin levels at the time of admission
title_fullStr Association between COVID-19 severity and relatively high serum adiponectin levels at the time of admission
title_full_unstemmed Association between COVID-19 severity and relatively high serum adiponectin levels at the time of admission
title_short Association between COVID-19 severity and relatively high serum adiponectin levels at the time of admission
title_sort association between covid 19 severity and relatively high serum adiponectin levels at the time of admission
topic adiponectin
covid-19
sars-cov-2
severity
acute phase of disease
url https://www.jstage.jst.go.jp/article/endocrj/71/7/71_EJ24-0072/_html/-char/en
work_keys_str_mv AT ryoheimineo associationbetweencovid19severityandrelativelyhighserumadiponectinlevelsatthetimeofadmission
AT shirofukuda associationbetweencovid19severityandrelativelyhighserumadiponectinlevelsatthetimeofadmission
AT shigehitosuzuki associationbetweencovid19severityandrelativelyhighserumadiponectinlevelsatthetimeofadmission
AT yoshitoito associationbetweencovid19severityandrelativelyhighserumadiponectinlevelsatthetimeofadmission
AT sachikotamba associationbetweencovid19severityandrelativelyhighserumadiponectinlevelsatthetimeofadmission
AT takuyasugiyama associationbetweencovid19severityandrelativelyhighserumadiponectinlevelsatthetimeofadmission
AT yuyafujishima associationbetweencovid19severityandrelativelyhighserumadiponectinlevelsatthetimeofadmission
AT hitoshinishizawa associationbetweencovid19severityandrelativelyhighserumadiponectinlevelsatthetimeofadmission
AT iichiroshimomura associationbetweencovid19severityandrelativelyhighserumadiponectinlevelsatthetimeofadmission
AT kojiyamamoto associationbetweencovid19severityandrelativelyhighserumadiponectinlevelsatthetimeofadmission
AT yujimatsuzawa associationbetweencovid19severityandrelativelyhighserumadiponectinlevelsatthetimeofadmission